518048-05-0;1100750-83-1 Raltegravir
| 상품명칭 |
Raltegravir |
| 영문 이름 |
Raltegravir; N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide |
| 분자식 |
C20H21FN6O5 |
| 분자량 |
444.4163 |
| InChI |
InChI=1/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30) |
| cas번호 |
518048-05-0;1100750-83-1 |
| 분자 구조 |
|
| 밀도 |
1.46g/cm3 |
| 굴절 지수 |
1.65 |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
KR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
